Analysts: Alexza Pharmaceuticals Inc (ALXA.O)

ALXA.O on Consolidated Issue listed on NASDAQ Capital Market

2.01USD
27 Mar 2015
Change (% chg)

$-0.02 (-0.99%)
Prev Close
$2.03
Open
$2.02
Day's High
$2.05
Day's Low
$1.99
Volume
15,060
Avg. Vol
113,258
52-wk High
$5.27
52-wk Low
$1.25

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.51 December 28 Mar 2015

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 1 1 1 1
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.50 2.50 2.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-15 2 3.36 4.50 2.22 --
Quarter Ending Jun-15 2 3.26 5.50 1.01 --
Year Ending Dec-15 4 15.07 25.30 6.18 34.86
Year Ending Dec-16 3 31.71 48.00 20.00 75.75
Earnings (per share)
Quarter Ending Mar-15 2 -0.51 -0.38 -0.65 --
Quarter Ending Jun-15 2 -0.54 -0.35 -0.72 --
Year Ending Dec-15 4 -1.79 -1.11 -2.75 -0.85
Year Ending Dec-16 3 -1.18 -0.50 -2.10 0.50

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-14 2.99 1.45 1.54 51.35
Quarter Ending Sep-14 1.73 0.46 1.27 73.54
Quarter Ending Jun-14 2.24 1.48 0.76 33.84
Quarter Ending Mar-14 1.91 2.17 0.25 13.14
Quarter Ending Dec-13 1.12 1.31 0.19 17.14
Earnings (per share)
Quarter Ending Dec-14 -0.68 -0.35 0.33 -48.53
Quarter Ending Sep-14 -0.74 -0.77 0.03 -4.76
Quarter Ending Jun-14 -0.67 -0.34 0.33 -49.00
Quarter Ending Mar-14 -0.63 -0.62 0.01 -2.36
Quarter Ending Dec-13 -0.76 -0.33 0.43 -56.58

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-15 3.36 4.50 4.50 4.50 --
Quarter Ending Jun-15 3.26 5.50 5.50 5.50 --
Year Ending Dec-15 15.07 18.03 20.10 21.95 34.86
Year Ending Dec-16 31.71 26.86 30.29 33.45 75.75
Earnings (per share)
Quarter Ending Mar-15 -0.51 -0.38 -0.54 -0.54 --
Quarter Ending Jun-15 -0.54 -0.35 -0.33 -0.33 --
Year Ending Dec-15 -1.79 -1.47 -1.23 -1.20 -0.85
Year Ending Dec-16 -1.18 -0.73 -0.84 -0.75 0.50

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-15 0 0 0 0
Quarter Ending Jun-15 0 0 0 0
Year Ending Dec-15 0 0 0 2
Year Ending Dec-16 1 0 1 0
Earnings
Quarter Ending Mar-15 0 0 1 0
Quarter Ending Jun-15 0 0 0 1
Year Ending Dec-15 0 0 1 1
Year Ending Dec-16 0 1 0 1

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks